GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Free Cash Flow per Share

Shanghai INT Medical Instruments Co (HKSE:01501) Free Cash Flow per Share : HK$-0.34 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Free Cash Flow per Share?

Shanghai INT Medical Instruments Co's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.34.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Free Cash Flow per Share or its related term are showing as below:

HKSE:01501' s 3-Year FCF Growth Rate Range Over the Past 10 Years
Min: -72.1   Med: -33.95   Max: 4.2
Current: 4.2

During the past 8 years, Shanghai INT Medical Instruments Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 4.20% per year. The lowest was -72.10% per year. And the median was -33.95% per year.

HKSE:01501's 3-Year FCF Growth Rate is ranked better than
53.03% of 628 companies
in the Medical Devices & Instruments industry
Industry Median: 1.9 vs HKSE:01501: 4.20

Shanghai INT Medical Instruments Co Free Cash Flow per Share Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Free Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Free Cash Flow per Share Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Free Cash Flow per Share
Get a 7-Day Free Trial -0.16 -0.39 -1.69 -0.80 -0.34

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Free Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 -0.20 -0.60 -0.37 0.03

Competitive Comparison of Shanghai INT Medical Instruments Co's Free Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Price-to-Free-Cash-Flow falls into.



Shanghai INT Medical Instruments Co Free Cash Flow per Share Calculation

Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.

Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.

Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.

Shanghai INT Medical Instruments Co's Free Cash Flow Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Free Cash Flow Per Share(A: Dec. 2023 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(194.852+-252.876)/170.864
=-58.024/170.864
=-0.34

Shanghai INT Medical Instruments Co's Free Cash Flow Per Share for the quarter that ended in Dec. 2023 is calculated as

Free Cash Flow Per Share(Q: Dec. 2023 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(122.455+-117.653)/172.227
=4.802/172.227
=0.03

Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Free Cash Flow per Share Explanation

Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.

In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.

This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over seven years. The reason we use seven years is because research shows that seven years is the length of the typical business cycle.

Therefore, as of Dec23, Shanghai INT Medical Instruments Co's Forward Rate of Return (Yacktman) % is

Forward Rate of Return (Yacktman) % (Dec23)=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=-0.53633333/28.6+0.1548
=13.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.


Shanghai INT Medical Instruments Co Free Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Free Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.
Executives
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Zhao Wei 2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Wang Kai 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd. 2201 Interest of corporation controlled by you
Zhang Wei 2501 Other
Worldwide Healthcare Trust Plc 2101 Beneficial owner
Orbimed Capital Llc 2102 Investment manager
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines